... SPIRIVA Placebo SPIR1VA Ipratropium [n = 550] [n = 371] [n » 356] [n = 179] Arthritis, coughing, and influenza-like symptoms occurred at a rate of 23% in the SPIRIVA treatment group, but were <1% in excess of the placebo group. Other ...
SPIRIVA. HandiHaler'. (tiotropium. bromide. inhalation. powder). Spiriva*. HandiHalef. (tiotropium bromide inhalation powder) Brief Summary of Prescribing Information FOR ORAL INHALATION ONLY DO NOT SWALLOW SPIRIVA CAPSULES INDICATIONS AND ...
SPIRIVA. HandiHaler'. (tiotropium. bromide. inhalation. powder). Spiriva*. HandiHaler5. (tiotropium bromide inhalation powder) Brief Summary of Prescribing Information FOR ORAL INHALATION ONLY DO NOT SWALLOW SPIRIVA CAPSULES INDICATIONS AND ...
SPIRIVA. HandiHaler'. (tiotropium. bromide. inhalation. powder). ADVERSE REACTIONS Of the 2,663 patients in the four 1-year. SPIRIVA®. HandiHaler®. (tiotropium bromide inhalation powder) For Oral Inhalation Only Brief Summary of Prescribing ...
SPIRIVA. HandiHaler8. (tiotropium. bromide. inhalation. powder). ADVERSE REACTIONS Of the 2,663 patients in the four 1-year. SPIRIVA0. HandiHaler*. (tiotropium bromide inhalation powder) For Oral Inhalation Only Brief Summary of Prescribing ...
... SPIRIVA in patients with COPD. Table 1 shows all adverse events that occurred with a frequency of >3% in the SPIRIVA group in the 1-year placebo-controlled trials where the rates in the SPIRIVA group exceeded placebo by >1%. The ...
... SPIRIVA HandiHaler (tiotropium bromide inhalation powder) is con- traindicated in patients with a history of hypersensitivity to atropine or its derivatives, including ipratropium, or to any component of this product WARNINGS SPIRIVA ...